Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +70 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602160 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +43.3 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602161 |
| 3 | = | Malignant Pancreatic Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602162 |
| 4 | = | Malignant Colon Neoplasm | +16.7 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602164 |
| 4 | = | Malignant Kidney Neoplasm | +16.7 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602163 |
| 6 | = | Malignant Liver Neoplasm | +16.6 | 83.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602165 |
| 7 | = | Malignant Esophageal Neoplasm | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602166 |
| 7 | = | Non-Hodgkin Lymphoma | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602167 |
| 9 | = | Malignant Vulvar Neoplasm | +10 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602168 |
| 10 | = | Multiple Myeloma | +6.7 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602169 |
| 11 | = | Malignant Salivary Gland Neoplasm | +6.7 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602170 |
| 12 | = | Malignant Laryngeal Neoplasm | +3.4 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602171 |
| 13 | = | Malignant Lung Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602172 |
| 14 | = | Cutaneous Melanoma | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602173 |
| 14 | = | Malignant Bladder Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602174 |
| 14 | = | Malignant Vaginal Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602175 |
| 17 | = | Malignant Anal Neoplasm | -3.4 | 46.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602176 |
| 18 | = | Malignant Mesothelioma | -3.4 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602177 |
| 19 | = | Malignant Prostate Neoplasm | -6.6 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602178 |
| 20 | = | Malignant Nasopharyngeal Neoplasm | -6.7 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602179 |
| 21 | = | Leukemia | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602180 |
| 21 | = | Malignant Breast Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602181 |
| 21 | = | Malignant Rectal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602182 |
| 24 | = | Malignant Hypopharyngeal Neoplasm | -10 | 23.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602183 |
| 25 | = | Malignant Ovarian Neoplasm | -16.7 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602184 |
| 26 | = | Hodgkin Lymphoma | -20 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602185 |
| 26 | = | Malignant Testicular Neoplasm | -20 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602186 |
| 28 | = | Malignant Penile Neoplasm | -23.3 | 10 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602187 |
| 29 | = | Malignant Thyroid Gland Neoplasm | -30 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602188 |
| 30 | = | Malignant Gastric Neoplasm | -36.7 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602189 |
| 31 | = | Malignant Cervical Neoplasm | -43.3 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602190 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 17aedb772017668fffec3111